Intense investigation into the predictors and determinants of post-acute sequelae of SARS-
CoV-2 infection (PASC), including 'long COVID', is underway. Recent studies provide clues …

An important challenge during the COVID-19 pandemic has been to understand
asymptomatic disease and the extent to which this may be a source of transmission. As …

Background Several autoimmune features occur during coronavirus disease 2019 (COVID‐
19), with possible implications for disease course, immunity, and autoimmune pathology. In …

Severe SARS-CoV-2 infection has been associated with highly inflammatory immune
activation since the earliest days of the COVID-19 pandemic,,–. More recently, these …

After COVID-19, some patients develop long-term symptoms. Whether such symptoms
correlate with immune responses, and how long immunity persists, is not yet clear. This …

Recent studies have provided insights into innate and adaptive immune dynamics in
coronavirus disease 2019 (COVID-19). Yet, the exact feature of antibody responses that …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used …

Long-COVID is a new emerging syndrome worldwide that is characterized by the
persistence of unresolved signs and symptoms of COVID-19 more than 4 weeks after the …

COVID-19 caused by SARS-CoV-2 infection has caused substantial morbidity and mortality
worldwide and paralyzed the international economy. Understanding the magnitude and …